A phase4 Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B

NCT05282407 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Tenofovir disoproxil 245mg
DRUG: Tenofovir disoproxil fumarate 300mg

Sponsor

Samjin Pharmaceutical Co., Ltd.